PharmaJet (United States)

Recent papers from PharmaJet (United States)

1. CCHFV-M based DNA vaccine is highly immunogenic in multiple species and protects against challenge in cynomolgus macaquesAntiviral Research · 2025
2. Novel Technologies for Intradermal Delivery of Fractional-Dose Inactivated Poliomyelitis Vaccine: Review of Implementation Research and Implications for Equitable Vaccine Access2025
3. Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injectionnpj Vaccines · 2024
4. Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) productJournal of Controlled Release · 2023
5. Improved DNA Vaccine Delivery with Needle-Free Injection SystemsVaccines · 2023
6. Immune Responses of a Novel Bi-Cistronic SARS-CoV-2 DNA Vaccine Following Intradermal Immunization With Suction DeliveryFrontiers in Virology · 2022
7. A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challengenpj Vaccines · 2022
8. A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous ProtectionViruses · 2019
9. A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human PrimatesFrontiers in Immunology · 2014
10. DNA Vaccination Elicits Protective Immune Responses against Pandemic and Classic Swine Influenza Viruses in PigsClinical and Vaccine Immunology · 2011